Browsing by Author "Uribe González, Pablo Francisco"
Now showing 1 - 16 of 16
Results Per Page
Sort Options
- ItemA real life use of ruxolitinib in patients with acute and chronic graft versus host disease refractory to corticosteroid treatment in Latin American patients(2020) Sarmiento Maldonado, Mauricio; Jara, V.; Soto, K.; Uribe González, Pablo Francisco; Ocqueteau Tachini, Mauricio; Bertín Cortes Monroy, Pablo; Pereira Garcés, Jaime Ignacio
- ItemAcneiform eruption in a patient with metastatic melanoma after ceasing combination dabrafenib/trametinib therapy(2014) Uribe González, Pablo Francisco; Anforth, R.; Kefford, R.; Fernández Penas, P.
- ItemAcneiform eruptions : a common cutaneous toxicity of the MEK inhibitor trametinib(2014) Anforth, R.; Liu, M.; Bao, N.; Uribe González, Pablo Francisco; Kefford, R.; Clements, A.; Long, G.; Fernández Penas, P.
- ItemCirculating vitamin D-binding protein and free 25-hydroxyvitamin D concentrations in patients with melanoma : a case-control study(2017) Navarrete Dechent, Cristián Patricio; Del Puerto Troncoso, Constanza; Molgó Novell, Montserrat; González Bombardiere, Sergio; Pérez Mateluna, Guillermo; Uribe González, Pablo Francisco; Camargo, Carlos A.; Borzutzky Schachter, Arturo; Navarrete Dechent, Cristián Patricio; Del Puerto Troncoso, Constanza; Molgó Novell, Montserrat; González Bombardiere, Sergio; Pérez Mateluna, Guillermo; Uribe González, Pablo Francisco; Camargo, Carlos A.; Borzutzky Schachter, Arturo
- ItemCompassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis(2017) Sarmiento Maldonado, Mauricio; Bertín Cortes Monroy, Pablo; Jara Arias, Verónica.; Soto Donoso, Katherine.; Uribe González, Pablo Francisco; Ocqueteau Tachini, Mauricio; Ramírez Villanueva, Pablo Antonio; Perez Simón, José Antonio.Abstract Background Ruxolitinib is a potent inhibitor of JAK1/2 with proven efficacy in myelofibrosis. In recent years, research in graft versus host disease (GVHD) has revealed the role of activation of JAK pathways in alloreactive lymphocytes. Some reports have shown significant responses in refractory GVHD patients. Cases presentation In this report we present our experience in 8 patients with acute or chronic GVHD with refractoriness to steroids and extracorporeal photopheresis treated with ruxolitinib. Three patients had acute GVHD (1 pulmonary, 2 cutaneous, 1 multi-systemic) and 5 had chronic GVHD (3 cutaneous); 85% obtained an overall response and 50% a complete response with a tolerable toxicity profile. Conclusions In our series, Ruxolitinib was very active as a rescue therapy for patients with acute or chronic GVHD refractory to standard treatment.
- ItemCutaneous embolism of an atrial myxoma(2015) Bandera, A.; Stewart, N.; Uribe González, Pablo Francisco; Minocha, R.; Choi, J.
- ItemDesmoplastic trichilemmoma dermoscopically mimicking molluscum contagiosum(2017) Navarrete, C.; Uribe González, Pablo Francisco; González Bombardiere, Sergio
- ItemDiffuse melanosis cutis in the setting of BRAF(V600E) mutant melanoma and treatment with targeted therapies(2015) Minocha, R.; Kefford, R.; Uribe González, Pablo Francisco; Sebaratnam, D.; Fernandez, P.
- ItemEntendiendo las terapias actuales en melanoma metastásico(2016) Rodríguez, Rocío; Parra, Angela; González Bombardiere, Sergio; Molgó Novell, Montserrat; Droppelmann, Nicolás; Acevedo Claros, Francisco Nicolás; Peña, José; Uribe González, Pablo Francisco
- ItemIn vivo confocal microscopy for the oral cavity: Current state of the field and future potential(2016) Maher, N.; Collgros, H.; Uribe González, Pablo Francisco; Ch'Ng, S.; Rajadhyaksha, M.; Guitera, P.
- ItemIn vivo reflectance confocal microscopy for the diagnosis of melanoma and melanotic macules of the lip(2017) Uribe González, Pablo Francisco; Collgros, H.; Scolyer, R.; Menzies, S.; Guitera, P.
- ItemInk-enhanced dermoscopy is a useful tool to differentiate acquired solitary plaque porokeratosis from other scaly lesions(2017) Navarrete Dechent, Cristián Patricio; Uribe González, Pablo Francisco; Marghoob, Ashfaq
- ItemNuevas terapias sistémicas para el tratamiento del melanoma(2016) Droppelmann, Nicolás; León Ramírez, Augusto; Goñi Espíldora, Ignacio; González Díaz, Hernán; Domínguez Covarrubias, Francisco José; Camus Appuhn, Mauricio Gonzalo; Nervi Nattero, Bruno; Uribe González, Pablo Francisco; Molgó Novell, Montserrat; Acevedo Claros, Francisco Nicolás
- ItemPerformance of a deep neural network in teledermatology : a single-centre prospective diagnostic study(2021) Ramirez Cornejo, Cristian Alejandro; Del Barrio Diaz, Pablo Ignacio; Jaque Silva, Ana Alejandra; Uribe González, Pablo Francisco; Majerson Bursztyn, David; Curi Tuma, Maximiliano; Del Puerto Troncoso, Constanza; Reyes Baraona, Francisco Javier; Parra Cares, Julio Alejandro; Vera Kellet, Cristián Andrés; Navarrete Dechent, Cristián Patricio; Muñoz-López, C.; Marchetti, M. A.; Han, S. S.; Meza-Romero, R.; Araneda-Ortega, P.; Guzmán, M.; Millán-Apablaza, R.; Nuñez-Mora, M.; Liopyris, K. ;
- ItemReflectance confocal microscopy in the evaluation of targetoid haemosiderotic haemangioma apropos two cases(2018) Navarrete Dechent, Cristián Patricio; Schwartz, Rodrigo; González, Salvador; González Bombardiere, Sergio; Abarzúa, Alvaro; Uribe González, Pablo Francisco
- ItemTelangiectasia hemorrágica hereditaria. Revisión a partir de un caso(2018) Vargas Ramírez, Emilio; Rojas Lechuga, María Jesús; Uribe González, Pablo Francisco